Galidesivir is a potent nucleotide analogue belonging to the guanosine analogue class, developed as a broad-spectrum antiviral agent primarily investigated for its efficacy against conditions such as hepatitis… Read more
Galidesivir is a potent nucleotide analogue belonging to the guanosine analogue class, developed as a broad-spectrum antiviral agent primarily investigated for its efficacy against conditions such as hepatitis B. By functioning as a viral DNA polymerase inhibitor, this compound effectively disrupts viral replication within infected cells. Research and quality control laboratories rely on high-quality Galidesivir reference standards to support rigorous analytical testing and method validation. The category includes essential related compounds such as Galidesivir DiHCl, the active triphosphate metabolite, and stable isotope labelled versions like Galidesivir-13C5. These compounds are critical for accurate impurity profiling and quantitative analysis in pharmaceutical development, enabling precise monitoring of drug metabolism, pharmacokinetics, and degradation pathways during the manufacturing and stability testing processes. Integrating these reference materials into analytical workflows ensures the reliability and reproducibility of results required for pharmaceutical regulatory compliance.